Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for nocturia in adults with progressive multiple sclerosis
2012-004183-21Phase 2Completed
- Sponsor
- North Bristol NHS Trust
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of melatonin in nocturia and multiple sclerosis (MS) (3 arms), sponsored by North Bristol NHS Trust. Primary endpoint: Reduction in nocturia episodes per night. Started Dec 2012; status: completed.
02
Drugs
melatonin
03
Conditions
nocturiamultiple sclerosis (MS)
Beyond the preview
Go deeper on 2012-004183-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004183-21.